Faculty Opinions recommendation of Cost-effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection.
2014 ◽
Vol 40
(6)
◽
pp. 657-675
◽
2013 ◽
Vol 11
(1)
◽
pp. 65-78
◽
2015 ◽
Vol 41
(6)
◽
pp. 544-563
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 73
◽
pp. 376